These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Bian J; Sun Y Mol Cell Biol; 1997 Nov; 17(11):6330-8. PubMed ID: 9343394 [TBL] [Abstract][Full Text] [Related]
4. Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells. Ala-aho R; Grénman R; Seth P; Kähäri VM Oncogene; 2002 Feb; 21(8):1187-95. PubMed ID: 11850838 [TBL] [Abstract][Full Text] [Related]
5. Regulation of MMP-9 by p53 in first trimester cytotrophoblastic cells. Cohen M; Wuillemin C; Irion O; Bischof P Hum Reprod; 2008 Oct; 23(10):2273-81. PubMed ID: 18635530 [TBL] [Abstract][Full Text] [Related]
6. Structural analysis and promoter characterization of the human collagenase-3 gene (MMP13). Pendás AM; Balbín M; Llano E; Jiménez MG; López-Otín C Genomics; 1997 Mar; 40(2):222-33. PubMed ID: 9119388 [TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Vincenti MP; Brinckerhoff CE Arthritis Res; 2002; 4(3):157-64. PubMed ID: 12010565 [TBL] [Abstract][Full Text] [Related]
8. Translational repression of human matrix metalloproteinases-13 by an alternatively spliced form of T-cell-restricted intracellular antigen-related protein (TIAR). Yu Q; Cok SJ; Zeng C; Morrison AR J Biol Chem; 2003 Jan; 278(3):1579-84. PubMed ID: 12426321 [TBL] [Abstract][Full Text] [Related]
9. Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis. Yamanishi Y; Boyle DL; Pinkoski MJ; Mahboubi A; Lin T; Han Z; Zvaifler NJ; Green DR; Firestein GS Am J Pathol; 2002 Jan; 160(1):123-30. PubMed ID: 11786406 [TBL] [Abstract][Full Text] [Related]
10. p53-dependent down-regulation of telomerase is mediated by p21waf1. Shats I; Milyavsky M; Tang X; Stambolsky P; Erez N; Brosh R; Kogan I; Braunstein I; Tzukerman M; Ginsberg D; Rotter V J Biol Chem; 2004 Dec; 279(49):50976-85. PubMed ID: 15371422 [TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2. Takeshita H; Yoshizaki T; Miller WE; Sato H; Furukawa M; Pagano JS; Raab-Traub N J Virol; 1999 Jul; 73(7):5548-55. PubMed ID: 10364303 [TBL] [Abstract][Full Text] [Related]
12. Constitutive expression and regulation of collagenase-3 in human breast cancer cells. Selvamurugan N; Partridge NC Mol Cell Biol Res Commun; 2000 Apr; 3(4):218-23. PubMed ID: 10891395 [TBL] [Abstract][Full Text] [Related]
13. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53. Subler MA; Martin DW; Deb S J Virol; 1994 Jan; 68(1):103-10. PubMed ID: 8254719 [TBL] [Abstract][Full Text] [Related]
14. ATF3 represses 72-kDa type IV collagenase (MMP-2) expression by antagonizing p53-dependent trans-activation of the collagenase promoter. Yan C; Wang H; Boyd DD J Biol Chem; 2002 Mar; 277(13):10804-12. PubMed ID: 11792711 [TBL] [Abstract][Full Text] [Related]
15. Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer. Elnemr A; Yonemura Y; Bandou E; Kinoshita K; Kawamura T; Takahashi S; Tochiori S; Endou Y; Sasaki T Gastric Cancer; 2003; 6(1):30-8. PubMed ID: 12673424 [TBL] [Abstract][Full Text] [Related]
16. Localization of a mutant p53 response element on the tissue inhibitor of metalloproteinase-3 promoter: mutant p53 activities are distinct from wild-type. Thomas S; Reisman D Cancer Lett; 2006 Aug; 240(1):48-59. PubMed ID: 16236433 [TBL] [Abstract][Full Text] [Related]
17. Reduction of cytokine-induced expression and activity of MMP-1 and MMP-13 by mechanical strain in MH7A rheumatoid synovial cells. Sun HB; Yokota H Matrix Biol; 2002 Apr; 21(3):263-70. PubMed ID: 12009332 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIF-1- and wild-type p53-stimulated transcription by codon Arg175 p53 mutants with selective loss of functions. Blagosklonny MV; Giannakakou P; Romanova LY; Ryan KM; Vousden KH; Fojo T Carcinogenesis; 2001 Jun; 22(6):861-7. PubMed ID: 11375890 [TBL] [Abstract][Full Text] [Related]
19. Characterisation of the cell type-specificity of collagenase 3 mRNA expression in comparison with membrane type 1 matrix metalloproteinase and gelatinase A in the synovial membrane in rheumatoid arthritis. Petrow PK; Wernicke D; Schulze Westhoff C; Hummel KM; Bräuer R; Kriegsmann J; Gromnica-Ihle E; Gay RE; Gay S Ann Rheum Dis; 2002 May; 61(5):391-7. PubMed ID: 11959761 [TBL] [Abstract][Full Text] [Related]
20. Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes. Willis A; Jung EJ; Wakefield T; Chen X Oncogene; 2004 Mar; 23(13):2330-8. PubMed ID: 14743206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]